2018
DOI: 10.1515/bmc-2018-0021
|View full text |Cite
|
Sign up to set email alerts
|

When Humans Met Superbugs: Strategies to Tackle Bacterial Resistances to Antibiotics

Abstract: Bacterial resistance to antibiotics poses enormous health and economic burdens to our society, and it is of the essence to explore old and new ways to deal with these problems. Here we review the current status of multi-resistance genes and how they spread among bacteria. We discuss strategies to deal with resistant bacteria, namely the search for new targets and the use of inhibitors of protein-protein interactions, fragment-based methods, or modified antisense RNAs. Finally, we discuss integrated approaches … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
31
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 26 publications
(31 citation statements)
references
References 71 publications
0
31
0
Order By: Relevance
“…Colistin is one of the few antimicrobial agents with efficacy against CRE infections; therefore, colistin resistance could enable CRE to become a “Superbug.” 38 In 2015, plasmid‐encoded colistin resistance gene, mcr‐1 , was discovered in China 39 . It has been reported that mcr genes are found worldwide and the risk of CRE turning into a “Superbug” is quite realistic 40 .…”
Section: Current Situation Of Cre In Japan and Worldwidementioning
confidence: 99%
“…Colistin is one of the few antimicrobial agents with efficacy against CRE infections; therefore, colistin resistance could enable CRE to become a “Superbug.” 38 In 2015, plasmid‐encoded colistin resistance gene, mcr‐1 , was discovered in China 39 . It has been reported that mcr genes are found worldwide and the risk of CRE turning into a “Superbug” is quite realistic 40 .…”
Section: Current Situation Of Cre In Japan and Worldwidementioning
confidence: 99%
“…This fact has resulted in today's eminent lack of new antibiotic drug leads, making us face a looming crisis that the emergence of resistance is outpacing the development of new antibiotics (Dickey et al, 2017;Woodworth et al, 2018). The previous admonitory terms of "gloom scenario, " "dark horizons, " and "back to the pre-antibiotic era" are becoming reality nowadays (Bravo et al, 2018). All these facts impel scientists to rapidly explore new chemical entities for developing novel antibiotics to target the emerging multidrug-resistant microbial pathogens that cause life-threatening infections.…”
Section: Introductionmentioning
confidence: 99%
“…(a) fractional genetic transfer, (b) fractional componential drift and (c) phenotypic continuance. Credits: adapted from Bravo et al ., 2018; Zeineldin; and Mirumur, 2011, 2014.…”
Section: Discussionmentioning
confidence: 99%